Focus on Obesity

Global obesity is on the rise, and endocrinologists are at the forefront of diagnosing its underlying causes and prescribing treatment plans. The Society works to reduce prevalence of obesity through various means, including development and release of scientific statements and practice guidelines, and advocacy for policies and positions that ensure access to affordable treatments. As new obesity medications come to market, the Society will play an important role in educating providers and patients on their optimal usage.

ENDO 2022 Research Highlight: New Findings in Anti-Obesity Medications

 

Obesity Epidemic

Obesity is a complex disease that is associated with various comorbidities, increased mortality, and reduced quality of life. Abdominal obesity is one of the components of metabolic syndrome (MetS), a cluster of risk factors that increases an individual’s risk for chronic conditions such as cardiovascular disease and diabetes. Our recent Obesity Report details the epidemiology of obesity and MetS by age, race, and geographic location and includes data on the direct costs associated with obesity and MetS. Learn more about the science of obesity in our 2021 Thematic Issue on Obesity

Statements and Practice Guidelines

Recent Resources and Advocacy Activity


Obesity Care

Society Supports the Treat and Reduce Obesity Act

We are proud to champion Obesity Care Week #OCW2022 to raise awareness about obesity. The Treat and Reduce Obesity Act (TROA) would take steps to give people with obesity access to the care they need.

We are proud to champion Obesity Care Week #OCW2022 to raise awareness about obesity. The Treat and Reduce Obesity Act (TROA) would take steps to give people with obesity access to the care they need.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.